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nuclear hormone receptor signaling (Smith et al., 1996;and its closely related family member CBP mediate
Yang et al., 1996; Yao et al., 1996; Chen et al., 1997;multiple, signal-dependent transcriptional events. We
Torchia et al., 1997).have generated mice lacking a functional p300 gene.
The ability of p300 and CBP to interact with multiple,Animals nullizygous for p300 died between days 9 and
signal-dependent transcription factors has led to the11.5 of gestation, exhibiting defects in neurulation, cell
proposal that these coactivators function as signal in-
proliferation, and heart development. Cells derived from
tegrators by coordinating complex signal transduction
p300-deficient embryos displayed specific transcrip-
events at the transcriptional level (Eckner et al., 1996a;
tional defects and proliferated poorly. Surprisingly,
Hanstein et al., 1996; Kamei et al., 1996; Oelgeschlager
p300 heterozygotes also manifested considerable em- et al., 1996; Yao et al., 1996). Depending on the context,
bryonic lethality. Moreover, double heterozygosity for specific transcription factors can either cooperate or
p300 and cbp was invariably associated with embry- interfere with each other. For example, during skeletal
onic death. Thus, mouse development is exquisitely muscle cell differentiation, MyoD and MEF2 family mem-
sensitive to the overall gene dosage of p300 and cbp. bers cooperate to activate synergistically thedifferentia-
Our results provide genetic evidence that a coactiva- tion program (Molkentin et al., 1995). In vivo, p300 and
tor endowed with histone acetyltransferase activity is CBP bind to members of both families and are required
essential for mammalian cell proliferation and devel- for the activity of MyoD and MEF2 proteins (Eckner et
opment. al., 1996a; Sartorelli et al., 1997). On the other hand,
transcriptional repression among certain transcription
Introduction factors also appears to be mediated by p300 and CBP.
On the collagenase promoter, members of the nuclear
p300 and CBP are members of a novel class of transcrip- receptor and AP-1 families strongly interfere with each
tional coactivators that are suspected of being funda- other, a phenomenon termed cross-coupling (Reviewed
mentally important in various signal-modulated tran- in Schule and Evans, 1991). Both types of transcription
scriptional events. Both proteins interact with a diverse factors bind p300 and CBP, and it has been suggested
collection of transcription factors that participate in a that repression results from competition for limiting
broad spectrum of biological activities such as cellular amounts of intracellular p300 and CBP (Kamei et al.,
differentiation, homeostasis, and growth control (re- 1996). These results suggest a complex mode of action
viewed in Shikama et al., 1997). p300 was originally for p300 and CBP in coordinating gene expression with
identified as one of the key cellular proteins targeted by signal transduction pathways.
theadenovirus E1A oncoprotein, while CBP was isolated In keeping with this notion, there are likely several
as a protein interacting with the cAMP-responsive tran- mechanisms by which p300 contributes to transcription
scription factor CREB (Whyte et al., 1989; Chrivia et al., control. For example, p300 and CBP both express a
potent histone acetyltransferase activity (HAT) (Bannis-
ter and Kouzarides, 1996; Ogryzko et al., 1996). In vitro,‖ To whom correspondence should be addressed.
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Figure 1. In Situ Analysis of p300 mRNA Tran-
script Expression in Mouse Embryogenesis
Dark-field micrographs of a transverse sec-
tion in the cranial region of an E12.5 (B) and
of parasagittal sectionsof E14.5 (D) and E16.5
(F) mouse embryos are presented after hy-
bridization with a 35S-a-ATP-labeled p300-
specific mouse antisense probe. Bright-field
micrographs of toluidine blue±stained sec-
tions are shown in (A), (C), and (E). Note the
widespread expression of p300 with elevated
levels in the central nervous system. Note
also the absence of specific signals when a
parallel section of the E16.5 embryo in (F) was
hybridized with the respective control sense
probe (G).Abbreviations: sc, spinal cord; npc,
neopallial cortex; lu, lung; li, liver; he, heart.
Scale bar 5 3 mm.
core histones. Since histone acetylation is known to be suggesting that the dose of the cbp gene is critically
important in humans.increased in transcriptionally active chromatin (Grunstein,
1997; Wade et al., 1997), it is possible that p300/CBP To investigate the function of p300 and CBP during
mouse development, we have disrupted both p300 andin part facilitates transcription by directly modifying
chromatin structure. cbp genes. In this report we will present the analysis of
p300 mutant animals. Animals lacking both p300 allelesSeveral lines of evidence indicate that deregulation of
p300 and CBP activity can causecellular transformation. died around mid-gestation despite the presence of nor-
mal quantities of highly homologous CBP. These em-Together with members of the retinoblastoma tumor
suppresser (pRB) protein family, p300 and CBP consti- bryos showed pleiotropic defects in morphogenesis and
cell differentiation and, unexpectedly, in proliferation. Intute the two major cellular targets of the viral oncopro-
tein E1A and large T antigen (Whyte et al., 1989; Eckner keeping with the latter defect, fibroblasts derived from
homozygous embryos also manifested a severe defi-et al., 1996b). Binding of p300/CBP by E1A stimulates
quiescent primary cells to proliferate and contributes to ciency in proliferation. Remarkably, there was also sig-
nificant embryonic lethality of mice lacking just one copyras-mediated cellular transformation (Howe et al., 1990;
reviewed in Moran, 1993). By analogy to pRB, which is of p300. Compound heterozygous mutants for p300 and
cbp invariably died in utero, demonstrating an absoluteinactivated upon E1A binding (Nevins, 1992), it is as-
sumed that E1A inactivates growth suppressing func- requirement for a certain combined level of these two
closely related proteins for normal animal development.tions of p300 and CBP. In keeping with this view, p300
and/or CBP can function as coactivators of p53 in the These results establish an essential gene dosage±sensi-
tive role for a mammalian coactivator/histone acetyl-induction of cell cycle arrest and apoptosis. These func-
tions of p300/CBP are abrogated by E1A (Avantaggiati transferase in embryogenesis, differentiation, and cell
proliferation.et al., 1997; Gu et al., 1997; Lill et al., 1997). Interestingly,
by acetylating p53, p300 and CBP can also up-regulate
the DNA binding activity of p53 (Gu and Roeder, 1997). Results
Another type of deregulation of p300 and CBP activities
occurs in some leukemias, where specific chromosomal p300 Expression in Mouse Embryogenesis
Analysis of the expression pattern of a gene duringtranslocations fuse p300 or cbp to partner genes (Bor-
row et al., 1996; Ida et al., 1997; Sobulo et al., 1997). mouse development can provide valuable insights re-
garding its function. As a prelude to disrupting the geneThe resulting fusion proteins likely exert oncogenic ac-
tivity, at least in part, by derailing the normal functions for p300, we have analyzed the distribution of its mes-
senger RNA at different stages of embryogenesis by inof p300/CBP.
The necessity for correct regulation of p300 and CBP situ hybridization. The transcript of p300 can be de-
tected as early as E7.5 (data not shown) and subse-family members to prevent human disease is under-
scored by the recent finding that cbp is mutated in Ru- quently in all the developmental stages that we have
examined (Figure 1). For the most part, p300 transcriptsbinstein Taybi syndrome (RTS, Petrij et al., 1995), a ge-
netic disease characterized by multiple developmental appear to be generally expressed in embryos, with an
elevated abundance in neural tissues. The almost ubiq-defects and severe mental retardation. Interestingly, af-
fected individuals are heterozygous at the cbp locus, uitous expression of p300 indicates that this protein
Mice Deficient in p300/CBP
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Table 1. Survival of the Progeny of p300 1/1, 1/2, and 2/2
Mice at Weaning and during Embryogenesis
Genotype
1/1 1/2 2/2
129/Sv 155 132 0
1 : 0.85
129 3 BL6 149 181 0
1 : 1.21
E9.5 13 31 10(2)
1 : 2.38 : 0.77
E10.5 55(1) 95(6) 47(20)
1 : 1.64 : 0.85
The top panel gives for each genotype of two different genetic
backgrounds (129/Sv and 129/Sv 3 BL6) the number of viable off-
spring derived from matings of animals heterozygous for p300. The
genotyping was carried out at weaning. The lower panel shows the
number of live embryos in relation to the three genotypes at E9.5
and E10.5, respectively. The number of dead embryos are indicated
in parentheses. The data in the bottom panel is taken from mice
with a 129/Sv 3 BL6 background.
were independently injected into blastocysts and gave
rise to germline-transmitting chimeric mice that were
used to breed homozygous mutant progeny. To test for
the generation of true null mutants, the p300 protein
Figure 2. Disruption of the p300 Gene in Mice level was analyzed by standardized Western blotting in
(A) Schematic drawing of the targeting vector. The configuration of primary fibroblasts derived from embryos of all three
the wild-type (wt) allele is shown at the top. In the targeting vector genotypes. As expected, the p300 protein level was
(middle), exons encoding the first Cys/His domain (C/H 1) are re-
reduced in 1/2 and not detected in 2/2 cells, whileplaced by a neomycin resistance gene cassette. The thymidine ki-
those of CBP and a putative family member, p400, werenase (tk) gene was used for negative selection. The structure of the
unperturbed and not up-regulated in all three genotypestargeted allele is shown at the bottom. The location of the two
external probes (a and b) used to confirm correct targeting events (Figure 2C). Similar results were obtained using specific
and the size of the diagnostic restriction fragments for probe a (used immunostaining as the assay (data not shown). These
for the Southern blot in [B]) are indicated. Abbreviations: A, Asp- results demonstrate the specificity of the relevant tar-
718; B, BamH1.
geting events.(B) Southern blot analysis of genomic DNAs isolated from the yolk
sacs of embryos derived from heterozygous parents. The DNA was
digested with BamH1 and detected by hybridization to probe a. The Embryonic Lethality in p300 Hetero- and
wild-type allele is 23 kb in length and the mutant allele is 16 kb. Homozygous Mice
(C) Western blot analysis of p300, CBP, and p400 protein levels in To examine the potential influence of genetic back-
fibroblast extracts derived from E10.5 embryos. Equivalent amounts ground, p300-targeted mice were crossed into either an
(100 mg) of whole cell extract from embryonic fibroblasts were
inbred (129/Sv) or heterologous (C57BL/6) background.probed with a p300 (RW128) or a CBP (AC26) specific antibody or
In both cases, fertile heterozygous animals were bornan antibody (RW144) that recognizes a putative family member,
p400. Compared with wild-type cells, p300 protein levels are re- and bred further. Genotyping of offspring from matings
duced in 1/2 cells. No p300 was detected in 2/2 cells. The expres- of heterozygous animals revealed that the homozygous
sion of the p300 family member CBP (middle panel) and of p400 p300 mutation results in embryonic lethality (Table 1).
(bottom) were comparable in all three genotypes. In addition, heterozygous mutant mice were underrepre-
sented among weaned pups (Table1). This phenomenon
was initially seen in both genetic backgrounds but wasdoes not act in a tissue-restricted manner and is consis-
tent with previous work suggesting that p300 is present persistently and particularly prominent in the 129/Sv
inbred background in which 55% fewer heterozygotesin all tissue culture cell lines examined (unpublished
data). were observed than expected assuming normal Mende-
lian inheritance. Since no neonatal lethality was seen, a
fraction of the heterozygous embryos must have diedp300 Gene Targeting
To study the functional importance of p300 in embryo- in utero. Indeed, a small number of 1/2 mutants were
found dead as early as at E10.5 (Table 1, bottom panel).genesis and other signal transduction events, we inacti-
vated the murine p300 gene. Exons encoding the first We noted that the more the heterologous 129 3 BL6
mice were bred against C57BL/6 mice, the less lethalityCys/His-rich domain, which is located near the N termi-
nus of p300, were replaced with a PGK-neo gene cas- among p300 heterozygous animals was observed (see
below, Table 2). This indicates that there is a modifiersette by homologous recombination (Figure 2A). Cor-
rectly targeted clones were identified by Southern gene(s) in BL6 mice that suppresses the lethality of the
p3001/2 state.analysis (Figure2B). Two different p3001/2 ES cell clones
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from that present in the 2/2 mutants (compare FigureTable 2. Viability of the Progeny of Matings between p3001/2
3C with 3B). Specifically, the neural tube defect of 1/2and cbp1/2 Mice at Weaning
embryos was confined to the anterior part of the hind-
Genotype
brain and the midbrain, with the rest of the neural tube
p300; CBP p300; CBP p300; CBP p300; CBP fused normally. This partial penetrance of exencephaly
1/1; 1/1 1/2; 1/1 1/1; 1/2 1/2; 1/2 is compatible with the restricted lethality observed among
1/2 embryos (see Table 1).Number 27 26 17 0
Observed ratio 1 0.96 0.62 0 Examination of histological sections prepared from
Expected ratio 1 1 1 1 the cranial area revealed, on the ventral side, collapse
of the lumen of the telencephalic vesicles, which mayMice heterozygous for either p300 or cbp were mated, and the
number and genotype of viable offspring was determined at wean- be due to the loss of hydrostatic pressure secondary to
ing. Note the absence of viable double heterozygous mice (p3001/2/ the open neural tube defect. On the dorsal side, exen-
cbp1/2). For these experiments, mice with a mixed 129 3 BL6 back- cephaly caused by the failure of neural tube closure can
ground were used, in which p3001/2 animals are no longer underrep-
be seen (compare Figures 3D and 3E). Abnormalitiesresented.
were also apparent in more rostral areas where neural
tissue of unknown origin filled the ventricle, which is
normally filled with fluid (marked with an asterisk in Fig-
In both geneticbackgrounds, nop300 nullizygous em- ure 3F). Moreover, the density of mesenchymal cells
bryos could be retrieved past E11.5. In the 129 3 BL6 was lower in the homozygous mutant embryos (compare
mixed background, most p3002/2 embryos were still Figures 3H and 3I), suggesting the possibility of a prolif-
alive at E8.5 and E9.5 (Table 1, bottom panel; data not eration defect in those cells (see below). Consistent with
shown). However, morphologically, p3002/2 embryos the difference in exencephaly morphology, a histologi-
could be distinguished from their wild-type littermates cal analysis of 1/2 embryos (Figure 3G) revealed a more
as early as at E8.5, and the defect became more obvious advanced, yet incomplete, closure of the neural folds in
at E9.5 (data not shown). At E10.5, 50% of the 2/2 the hindbrain region than in the corresponding region
embryos were already dead as judged by either absence of 2/2 embryos (compare Figures 3G and 3E), indicating
of obvious heart beating or the presence of signs of a milder morphogenetic defect of the neural tissue in
reabsorption (Table 1, bottom panel). The p3002/2 em- 1/2 than in 2/2 embryos. Moreover, the neural tube
bryos dissected at E10.5 were much smaller than their of many of the p300 2/2 embryos also had a kinked
wild-type littermates and were developmentally retarded shape instead of a straight one, and the somites ap-
(Figure 3A). Frequently, the most severe but still vi- peared to be less organized (compare Figures 3J and
able mutant embryos had not completed an embryonic 3K). These results suggest a dosage-dependent role of
process referred to as ªturningº (Figure 3A) and con- p300 in the processes of neural tube closure.
tained 12±16 somites, indicating developmental arrest
at zE8.5±E9.0.
In general, p3002/2 129 3 BL6 embryos tended to Abnormal Heart Development
Because neural tube defects generally do not result inarrest a day or so later than 129/Sv embryos. A few of
the 129 3 BL6 embryos survived beyond E10.5. These early embryonic lethality, we sought to determine if other
developmental abnormalities can be seen in p300 mu-embryos displayed a less-disordered phenotype and
reached E11.5, after which they died. These late-arrest- tant embryos. We noticed that at E10.5, z20% of the
homozygous mutants showed an enlarged heart cavitying p3002/2 129 3 BL6 embryos were again smaller
than their wild-type littermates but displayed no gross and the yolk sac was often poorly vascularized (Figure
4A). Upon closer examination, mutant embryos dis-patterning abnormalities (Figure 3B). However, they ex-
hibited a severe open neural tube defect (NTD). Nor- played a severe pericardial effusion (Figure 4B), a clear
sign for a dysfunctional embryonic heart. Although nomally, the neural tube begins to close at E8.5 and com-
pletes closure by E9.5. However, in all p3002/2 mutants overt patterning defect was visible, detailed histological
inspection revealed that ventricular chambers of mutantand some 1/2 embryos (see below), neural tube closure
was defective. Eventually, various degrees of exenceph- embryos exhibited significantly reduced trabeculation
compared to matched wild-type littermates (comparealy were observed in all p300 nullizygous embryos (Fig-
ures 3A and 3B). Typically, the neural tube failed to fuse Figures 4C and 4D). On a functional level, we observed
that heart contractions in mutant embryos appeared tofrom hindbrain to the forebrain region (Figure 3B) or
remained completely open in the most severely affected be weaker and less extensive than in wild-type embryos.
To assess the status of cardiac myocyte differentiation,mutants (Figure 3A). The heterogeneity in the severity
of p300 mutants, at least in the 129 3 BL6 background, we analyzed theexpression of two cardiac muscle struc-
tural proteins, myosin heavy chain (MHC) and a-actinin,indicates a partial penetrance of the phenotypes possi-
bly due to the existence of genetic modifiers. in mutantand wild-type E9.5 embryos. Expression levels
of MHC (Figures 4E and 4F) or a-actinin (data not shown)Remarkably, in both 129 3 BL6 and 129/Sv mice, a
significant number of 1/2 embryos also revealed exen- were significantly lower in cardiac tissue of mutant com-
pared to wild-type embryos. Taken together, the abovecephaly. It was calculated that 6% of 129 3 BL6 (6 out
of 101 E10.5 1/2 embryos analyzed) and 19% of 129/ results indicate that heart development is perturbed in
embryos lacking p300 and raise the possibility that fail-Sv (16 out of 79) 1/2 embryos displayed this phenotype.
The exencephaly was generally restricted to the cranial ure of the cardiovascular system may, at least in part,
be responsible for the observed embryonic lethality.region and had a different morphological appearance
Mice Deficient in p300/CBP
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Figure 3. p300 2/2 and a Fraction of 1/2 Mutants are Developmentally Retarded and Show Defects in Neurulation
A comparison of mutant (2/2 or 1/2) and control (1/1) embryos by whole-mount (A±C) or by histological analysis (D±K).
(A) A severe 2/2 mutant (right) and a wild-type littermate (left) isolated at E10.5 are shown. The 2/2 embryo is much smaller than the 1/1
embryo, and it has not completed the process of turning as is evident in the tail region (arrow head). The neural tube (arrow) is open along
its full length.
(B) A less-dramatically affected 2/2 mutant (right) and a wild-type littermate (left) at E11.5 are shown. In the mutant embryo, the neural tube
is completely open in the cranial region; however, it is fused in the spinal region. Obvious exencephaly can be observed in the hindbrain
(arrow) and the rest of cranial region as well (arrowhead). The eye (E) is smaller in the mutant, and the facial structure appears to be collapsed.
Note that both limb buds (L) appear to be normal in the mutant embryos.
(C) A p3001/2 mutant (right) with exencephaly and a wild-type littermate (left) at E10.5 are shown. This heterozygous embryo displays
symmetrical exencephaly mostly in the midbrain and part of the hindbrain region (arrow). The morphology of exencephaly shown by 1/2
embryos is distinct from that of a 2/2 mutant (B). Note that 1/2 embryos with exencephaly were always somewhat smaller than control 1/1
littermates. B, branchial arch; H, heart.
(D±G) Transverse sections through the hindbrain and forebrain of E11.5 wild-type (D), 2/2 (E and F), and 1/2 mutant (E10.5) embryos. Both
2/2 (E) and 1/2 (G) mutants show exencephaly in the hindbrain region. However, the patterns of exencephaly are different in these two
embryos (open asterisk in G). The neural lumen (ventricle) is collapsed in both the 2/2 and 1/2 mutants (arrowheads in [D], [E], and [G]). In
a more rostral section, an abnormal mass of neural tissue (filled asterisk) was regularly observed in 2/2 embryos (e.g., in [F]). R, Rathke's
pouch.
(H and I) Representations of (D) and (E) at higher magnifications. The density of mesenchymal cells is much reduced in the 2/2 embryo (I)
compared to the wild-type embryo (H)
(J±K) Frontal sections of E10.5 embryos. The neural tube of the 2/2 animal often had a kinked morphology (arrow in [K]) in contrast to a
straight one that was always observed in wild type (J). The somites of the 2/2 often appeared to be disorganized as well (brackets in [J] and
[K]).
Scale bars 5 1 mm (A±C, J, K); 0.5mm (D±K).
p300 Is Required for Normal Cell Proliferation fewer labeled nuclei were detected in sections derived
from p3002/2 embryos (Figure 5B) compared to thoseAs shown above, embryos lacking p300 were always
significantly smaller than their wild-type littermates. One derived from wild-type embryos (Figure 5A) in the mes-
enchymal and/or neural crest cells surrounding the neu-explanation for this difference may be that cell prolifera-
tion is reduced in p3002/2 embryos. To determine the ral tube. Under higher magnification, it was also clear
that BrdU incorporation was much more uniform and in-fraction of cells actively synthesizing DNA, 5-bromo-29-
deoxy-uridine (BrdU) incorporation was assessed. Fig- tense in the wild-type cells (compare Figures 5C and 5D).
To demonstrate that the proliferation defect observedure 5 shows sections derived from the upper-trunk
region of homozygous E9.5 mutant and wild-type em- in animals is cell autonomous rather than a complete
secondary defect, fibroblasts derived from p300 mutantbryos. Nuclei in S-phase are labeled red. Significantly
Cell
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Figure 4. Cardiac Development in p3002/2
Mutants
(A) A p3002/2 embryo (left) and a wild-type
littermate (right), both still contained in their
yolk sacs, are shown at E10.5. The mutant
embryo displayed an enlarged heart (open
arrow), and the yolk sac was poorly vascu-
larized when compared to that of a control
littermate (filled arrow).
(B) A higher magnification of an E10.5 2/2
embryo with an enlarged heart and a severe
pericardial effusion. Note the abnormally en-
larged space between the pericardial mem-
brane (filled arrowhead) and the heart itself
(open arrow).
(C andD) A frontalsection of the E10.5 mutant
heart (D) reveals much less extensive trabec-
ulation (arrows) compared with that of a con-
trol littermate (C).
(E and F) A transverse section of E9.5 em-
bryos stained with antibody to the cardiac
muscle structural protein MHC. The staining
is much lower in the mutant heart (F) than in
the wild type (E). Note that cardiac trabecu-
lation (arrowhead) is also much more exten-
sive in the wild-type heart.
Scale bars 5 1 mm (B) and 0.1 mm (C±F).
and wild-type animals were isolated and their growth domain was used to activate a reporter gene containing
multiple Gal4 sites in its promoter (Figure 6B). By con-curves were determined. Repeatedly, p3002/2 cells grew
much more slowly than p3001/2 or p3001/1 MEFs, which trast, the activity of the transcription factor CREB stimu-
lated by protein kinase A was comparable in p300 2/2appear to have proliferated at a comparable rate (Figure
5E). Furthermore, unlike the heterozygous and wild-type and 1/1 cells (Figure 6C). Taken together, these results
lend support to the notion that p300 indeed functionscells, p3002/2 cells stopped dividing after three to four
cell generations (data not shown). These results demon- as a critical RAR cofactor. On the other hand, in the
context of this assay, p300 does not appear tobe criticalstrate a major cell proliferation and lifespan defect asso-
ciated with p300 deficient cells. for CREB-dependent gene activity.
Impaired Activity of the Retinoic Acid Receptor
in p300 2/2 MEFs Embryonic Lethality of p300 and CBP Compound
Heterozygous AnimalsThe results of numerous studies suggest that p300 and/
or CBP act as transcriptional coactivators for several To further study the role of p300 and CBP in mouse
embryogenesis, we also generated mice lacking CBP.members of the nuclear receptor superfamily. The avail-
ability of cells lacking p300 allowed us to investigate Similar to p300 mutants, animals homozygous for the
disrupted cbp allele showed complete embryonic lethal-receptor activity in a defined genetic background. To
this end, wild-type and p3002/2 MEFs were transfected ity. They also displayed open neural tube defects similar
to those seen in p3002/2 embryos (Figure 7A; a detailedwith an RAR-responsive reporter gene, and the re-
sponse to retinoic acid was examined. As shown in description of CBP mutants will be presented else-
where). To generate double heterozygous p300/cbpFigure 6A, RAR activity was significantly compromised
at all RA concentrations tested. Similar results were knockout mice, we mated animals heterozygous for
p300 and cbp. Surprisingly, no viable compound hetero-obtained when a chimeric protein containing the Gal4
DNA binding domain fused to the RAR ligand binding zygous mutants were detected at the time of weaning
Mice Deficient in p300/CBP
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7B) and exhibited open neural tube defects similar to
that observed in p300 or cbp homozygous mutants (Fig-
ures 7C, 7D, and 3B). Thus, p300 and cbp single-homo-
zygous as well as compound-heterozygous mutants all
display similar embryonic phenotypes. Together, these
results demonstrate that the combined dose of p300
and cbp is critical for mouse embryonic development.
In addition, the results imply that there are important,
common embryonic biochemical functions of p300 and
CBP.
Discussion
Previous studies in tissue culture cells have suggested
that p300 and CBP operate at the end points of signal
transduction pathways, which activate specific gene ex-
pression programs in response to incoming signals. The
gene expression programs thought to be regulated by
p300/CBP include those involved in cell differentiation,
growth control, and cellular homeostasis. The present
work was aimed at testing this notion as well as the
potential importanceof p300 and CBP function in mouse
development. These questions were posed at the hands
of discrete loss-of-function mutations in mice.
Four major conclusions emerged from our analysis.
First, p300 and cbp are essential genes for mouse
embryogenesis. Second, the embryonic phenotypes of
p3002/2, cbp2/2, and compound p300/cbp heterozy-
gotes are similar, and, unexpectedly, normal mouse de-
velopment is sensitive to the p300 and cbp gene dosage.
Third and equally surprising was the observation that
p300 is essential for normal cell proliferation in vivo
and in vitro. Fourth, signaling by retinoic acid is grossly
compromised in cells lacking p300, while cAMP (Figure
6) dependent signaling is not.
The early embryonic lethality is a surprise given the
presence of normal levels of the highly homologous pro-
tein CBP. This result together with the reduced viability
of the heterozygous mutants, the nonviability of the
Figure 5. p300-Deficient Embryos and Cells Show Growth Defects
compound heterozygotes, and the similarity of the gross
(A±D) Transverse sections of E9.5 embryos were stained with a
anatomical features of these various embryos not onlyBrdU-specific antibody. The embryos were pulse-labeled with BrdU
establishes p300 and cbp as essential genes, it alsofor 1.5 hr in utero. The p3002/2 embryo (B) had many fewer BrdU-
implies that these two proteins exert certain commonpositive cells (red) than its wild-type littermate (A). (C) and (D) are
higher magnification images of (A) and (B), respectively. Note that embryonic survival functions. Since both p300- and
the BrdU staining is both much more uniform and stronger in the CBP-deficient embryos suffered early lethality, this in
wild-type embryo. Neural tube (arrow) remains open in the mutant turn indicates that there is a significant p300 and cbp
embryo. Scale bar 5 0.1 mm
gene dosage requirement during embryogenesis. Ob-(E) In vitro proliferation analysis. Embryo fibroblasts were derived
servations made in patients with human RTS syndromefrom E10.5 embryos of all three genotypes. Identical numbers of
and in adult mouse cbp heterozygotes are consistentcells of each genotype were plated. The growth of these various
cultures was measured by counting the total number of cells on with this hypothesis (Petrij et al., 1995; Tanaka et al.,
each of the indicated days. A representative experiment is shown 1997; T. P. Y. and D. M. L., unpublished data).
using fibroblasts of embryos derived from parents with mixed 129 3 The gene dosage effects bear further discussion. Two
BL6 backgrounds. Similar results were obtained from three different
generic possibilities could explain them. First, one mightbatches of fibroblasts of each genotype. We noted that p3002/2
propose that CBP and p300 can perform numerous com-fibroblasts from 129 inbred embryos exhibited even more severe
mon biochemical functions. Given the panoply of differ-proliferative defects than fibroblasts shown in this experiment (data
not shown). ent transcription factors with which the two proteins
interact and coactivate, it seems fair to argue that p300
and CBP participate in many intracellular signaling path-
ways. Indeed, the number of pathways might be so large(Table 2), indicating that compound heterozygous em-
bryos died in utero. Indeed, like both p3002/2 and cbp2/2 that a drop in the combined level of these proteins of
only 0.25-fold (i.e., loss of one allele of p300) leaves asembryos, the compound heterozygous embryos were
also severely stunted compared to littermates (Figure many as half of the embryos unable to complete at least
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Figure 6. Transcriptional Activity of the Reti-
noic Acid Receptor but Not of CREB Is Im-
paired in p3002/2 Cells
The activity of endogenous RAR (A) and a
Gal±RAR fusion protein (B) in response to all
trans-retinoic acid was measured in p300 1/1
and 2/2 primary fibroblasts using bRARE-
luciferase and Gal4-luciferase, respectively,
as reporters. CREB activity (C) was measured
in the absence or presence of the catalytic
subunit of protein kinase A (PKA) using so-
matostatin-CRE-luciferase as a reporter plas-
mid (this unpublished reagent was the gener-
ous gift of Dr. Marc Montminy). The response
to all trans-retinoic acid (RA) in 2/2 cells
was reduced compared to that in 1/1 cells
at all concentrations of RA tested. At the same
time, PKA-dependent CREB activity was com-
parable in 1/1 and 2/2 cells.
one function essential for development and survival be- Not all p300 and CBP functions are similar. We did
observe that despite the presence of normal levels ofyond E9.0±E11.5.
In keeping with our findings and the above-noted CBP, p3002/2 fibroblasts were defective in retinoic acid±
dependent transcription. By contrast, they displayedmodels, Rosenfeld and coworkers have provided bio-
chemical evidence from transfection experiments that normal CREB function, indicating that they have not
undergone a general defect in transcription. Consistentimplies that proper integration of transcription signaling
by p300/CBP requires a critical level of these proteins with our results, it has been shown by a ribozyme ap-
proach using F9 EC cells that p300, but not CBP, is(Kamei et al., 1996). If one considers the evidence from
the transfection experiments together with the genetic required for retinoic acid signaling (K. Yokoyama, per-
sonal communication). These findings, albeit limited inevidence presented here, one can propose an explana-
tion for the phenomenon of cross-coupling or interfer- scope, imply that at least in embryonic cells p300 and
CBP can also exert certain distinct, nonoverlappingence between transcription factors observed in the past
by numerous investigators (reviewed in Schule and Ev- functions.
These data notwithstanding, the nonoverlap of p300ans, 1991). In a model that is relevant to the data pre-
sented in this report, an appropriate transcription factor and CBP biochemical functions does not appear to ex-
tend to certain major operations for which these proteinsA present at an elevated level engages a number of
molecules of p300 and/or CBP, committing them to its are responsible. This is because there were striking simi-
larities in the embryonic phenotypes of p300, cbp2/2,coactivation and preventing them from coactivating at
least one other specific transcription factor B. Thus, in and compound heterozygous knockout embryos (Fig-
ures 3 and 7). Hence, these two proteins must alsothe absence of its p300 or CBP coactivator, which at
that moment in time is committed to cooperating with perform a number of operations in common, at least
during early embryogenesis.A, transcription factor B cannot function at a normal
rate. In a 129/Sv background, a high (but not absolute)
degree of embryonic lethality was associated with lossIn a second possible explanation for the gene dosage
effects, one might argue that despite theirhigh structural of one p300 allele. p300 heterozygotes represent one
of the rare caseswhere haplo-insufficiency of a mamma-similarity and lack of biochemical individuality in trans-
fection experiments, the physiological functions of p300 lian gene leads to lethality. Indeed, most heterozygous
gene disruption experiments do not result in this effect.and CBP do not fully overlap, at least during embryonic
development. Thus, a reduction in the dose of one of A notable exception is the VEGF knockout, in which
all heterozygous embryos died (Carmeliet et al., 1996;them cannot be fully compensated by a call on the other
to cover the functional deficit. Ferrara et al., 1996). It is important to note that there
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Figure 7. Morphology of cbp2/2 and p3001/2/cbp1/2 Compound Heterozygous Mutants
(A) A cbp2/2 mutant embryo displays open neural tube defects (arrow) similar to those seen in p3002/2 embryos (for comparison, see Figure
2B).
(B) A p3001/2/cbp1/2 compound heterozygous mutant (smaller embryo) is pictured next to a p3001/1/cbp1/2 littermate (left) at E10.5.
(C) Side and dorsal (D) views of the compound heterozygous mutant that exhibits a severe open neural tube defect. Open neural tube (C)
and extensive exencephaly (D) are indicated by arrows. Note that the neural tube is fused normally (arrowhead) in the region caudal to the
hindbrain, which remains open in the compound heterozygous mutant embryo shown here. Scale bar 5 0.8 mm.
appears to be a modifier gene(s) in BL6 mice that sup- effect of the pocket protein(s) on cell proliferation. Given
this and the fact that E1A binding suppresses p300/presses p3001/2 lethality. Thus, one or more strain-spe-
cific genes can make embryos more (or less) susceptible CBP transactivating function, it has been widely as-
sumed that p300/CBP, like the pocket proteins, are alsoto a decrease in p300 or cbp gene dosage.
It was remarkable, however, that the embryonic lethal- active growth suppressers. It was thus unexpected that
p3002/2 embryos and cultured cells derived from themity in the 129/Sv background stands in contrast to the
lack of overt defects in heterozygotes that survived reveal significant retardation of proliferation. p3002/2
embryos were invariably stunted, and, where tested,embryogenesis. Thus, once such 1/2 embryos have
completed gestation, the absolute dependence on p300 their tissues revealed reduced DNA synthesis by in situ
methodology. These results indicate that p300 is re-dosage for viability is lost. This result argues that em-
bryogenesis (in the 129/Sv strain reported here) repre- quired for growth stimulation and imply that E1A±p300
complexes are even more active in this regard. Howsents a limited period characterized by much greater
sensitivity to perturbation in p300 gene dosage than these complexes operate to achieve this effect is unclear
at present. However, it is worth speculating that therepost-natal life. There may also be sufficient variation in
the abundance of p300 at critical times during develop- is a link between p300 function and the stable expres-
sion of the catalytic subunit of the telomerase genement so that depending upon whether the protein con-
centration is sub- or supercritical, the embryo either dies (Meyerson et al., 1997; Nakamura et al., 1997). Loss of
expression of this gene accompanies senescence, andor survives.
p300 and CBP, both E1A binding proteins, have been its forced expression overrides the limited lifespan phe-
notype of primary human (Bodnar et al., 1998). One won-assumed to function as growth and transformation sup-
pressing elements. The basis for this assumption is that ders whether the excessively limited lifespan of p3002/2
primary cells is related to premature cessation of te-at least part of the E1A stimulation of cell cycle progres-
sion is linked to its binding to both nuclear pocket pro- lomerase expression and/or failure of its activation. In
keeping with the view that p300 is a growth-promotingteins (i.e., Rb family members) and to p300/CBP (re-
viewed in Moran, 1993). E1A binding releases a negative element is the discovery of spontaneously occurring
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human p300 fusion proteins that appear to contribute We also hypothesize that the severe developmental
phenotype observed in the p3002/2, cbp2/2, and com-to leukemia development (Ida et al., 1997). Alternatively,
p300 might be a cellular protein endowed with both pound heterozygous embryos reflects a defect not in a
single signaling response but rather in the simultaneousgrowth-suppressing and -stimulating activities.
The early death of p3002/2 mutant embryos has pre- coordination of multiple signaling events, e.g., in cross-
coupling. It is also possible that the transcriptional defi-vented us from examining the behavior of several impor-
tant differentiation programs, such as skeletal muscle cits associated with the lack of p300 are only incom-
pletely revealed in standard transfection assays. Fordifferentiation, that appear to be dependent on p300
and/or CBP based upon evidence obtained in cultured example, p300 can function as a histone acetyltransfer-
ase. Conceivably, its activity in this regard only becomescells (Eckner et al., 1996a; Puri et al., 1997). The present
study, however, supports the view, which arose from essential in the context of a physiologically folded chro-
matin structure, which is not faithfully reproduced inanalysis of the results of studies in tissue culture cells,
that p300 participates in certain cellular differentiation transiently transfected model reporter plasmids (Dillon
and Grosveld, 1993).programs. The heart is the first organ of a mouse embryo
to achieve full functionality. Inspection of this organ in Given the observations reported here, a major goal
will now be to understand the biochemical basis forp3002/2 embryos revealed defects of cardiac muscle
differentiation and in trabeculation. Expression of the p300/cbp dosage dependence and p300 cellular prolif-
eration control. Detailed analysis of selected p300 mu-structural proteins myosin and a-actinin was clearly re-
duced in mutant hearts compared to the wild-type tant genes is likely to provide significant insights into
these mechanisms. Understanding them should in turnhearts of littermates.
Expression of cardiac muscle structural proteins de- shed light on how a critical number of molecules of p300
and CBP connect so many seemingly disparate andpends on members of the MEF2 transcription factor
family (Lin et al., 1997). Although it is formally possible highly complex transcriptional functions to events that
are essential for embryonic growth, organ development,that the heart defect is secondary to a developmental
delay observed in p3002/2 mutant embryos, we showed and cellular homeostasis.
earlier that MEF2 proteins, which also regulate cardiac
Experimental Proceduresdevelopment, bind to p300 and CBP in vivo (Eckner et
al., 1996a). Thus, we speculate that the impaired activity
Generation of ES Cells Heterozygous for p300of MEF2 proteins in the absence of p300 underlies the
An 129 mouse genomic l EMBL3 phage library (gift of Dr. Gerard
observed defects in the expression of certain myocar- Grosveld) was screened with a probe derived from the 59 end of
dial contractileproteins. Such a conclusion is supported the murine p300 cDNA. The locations of exons were mapped by
Southern blotting and PCR analyses. The precise exon±intronby a recent report showing that p300 stimulates cell
boundaries were determined by sequencing. The targeting vectortype±specific gene expression in cardiac myocytes (Ha-
was constructed with an 11 kb Asp-718 genomic fragment. First, asegawa et al., 1997). Taken together, our results argue
ca. 2 kb genomic BstXI±BglI fragment encompassing two completethat p300 is required for proper heart development. The
exons and a part of another two exons was deleted and replaced
cardiac defects in p3002/2 embryos may constitute a by a BamHI linker. The BstXI and BglI sites used are both located
major reason for the lethality observed between E9.0 within exons. The deleted exons encoded the first Cys/His-rich re-
gion. Subsequently, a PGK-neo cassette was cloned as a BglII frag-and E11.5.
ment into the newly inserted BamHI site. Finally, a SalI fragmentAll p3002/2 embryos displayed an open neural tube
containing the negative selection marker PGK2 (Clarke et al., 1992)defect. Although many murine mutations have been
was inserted at the 59 end of the 11 kb fragment. J-1 ES cells (Li etshown to affect tube closure, the phenotype of p3002/2
al., 1992) were electroporated with the targeting plasmid linearized
mutants shows some similarities to that of a mouse twist by HpaI. From 140 analyzed ES cell colonies surviving selection
mutant, which also dies at zE10.5 (Chen and Behringer, with G418 and FIAU, 3 contained a correctly targeted allele. These
cells were individually injected into blastocysts derived from C57Bl/61995). Interestingly, a mutation of the Drosophila p300/
mice. Two of the three ES cell clones gave rise to chimeric micecbp homolog dcbp affects the normal expression of
that transmitted the targeted allele to the germline.Drosophila twist due to a defect in the transcription
activity of dorsal (Akimaru et al., 1997). Dorsal activates
Histological Analysis
twist and, like its mammalian relative NF-kB, requires a Embryos of various stage were isolated and fixed in either Bouin's
p300/CBP family member to function in transcription solution or 4% paraformaldehyde for 2±4 hr at room temperature,
(Gerritsen et al., 1997; Perkins et al., 1997). Thus, it is dehydrated in ethanol series, cleared in xylene, and embedded in
paraffin. Sections were cut at 6±7 mm and either stained with hema-possible that the neural tube defect of p3002/2 embryos
toxylin and eosin or processed for immunostaining.is due to a defect in murine twist. A defect in other p300-
dependent transcription factors required for proper neu-
BrdU Labeling and Immunohistochemistry
ral tube morphogenesis, such as AP-2 and PAX-3, may E9.5 embryos were labeled with BrdU by injecting pregnant mice
also contribute to the neural tube defect (Epstein et al., with 0.5 ml of BrdU/PBS solution (3 mg/ml). The mice were sacrificed
1991; Schorle et al., 1996). 1.5 hr later, and embryos were isolated and processed as described
above. For immunohistochemistry, the proper sections were rehy-The retinoic acid±dependent transcription defect ob-
drated, partially digested with proteinase (25 mg/ml, bacterial typeserved in p3002/2 cells, while distinct, was not complete.
XXIV, Sigma) and then reacted with specific antibody. The detectionMoreover, the same cells displayed certain normal tran-
of BrdU incorporation was performed following the manufacturer's
scriptional responses (such as that mediated by CREB) instructions (Cell Proliferation Kit, Boehringer Mannheim). For myo-
in which p300 and/or CBP have long been assumed to sin heavy chain staining, monoclonal antibody MF20 was used, and
participate. Hence, these cells are not generally defec- the detection phase was carried out using the ABC kit (AP Kit,
Vector).tive in polymerase II transcriptional responses.
Mice Deficient in p300/CBP
371
Preparation of Mouse Fibroblasts and Analysis Yang for technical help; and Dr. Arlene Sharpe for advice on ES cell
growth. We wish to thank Drs. Henry Sucov and Pamela MitchellEmbryos showing a clearly visible heartbeat were isolated at E10.5,
for their invaluable advice during ouranalyses of murine embryogen-decapitated, and dissociated by gentle pippeting and trypsin diges-
esis. We also thank our laboratory colleagues for many helpful andtion. The dissociated fibroblasts were allowed to settle and then
enlightening discussions. This work was supported by grants fromcultured in standard DMEM containing 10% serum (Fetal Clone I,
the National Institutes of Health (NCI) and from the Novartis DrugHyclone). The viability of fibroblasts was comparable among all
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M. F. was supported by a fellowship from the Deutsche Forschungs-
gemeinschaft.Transfection and Plasmids
Transfection was performed using Lipofectamine (GIBCO BRL).
Received January 21, 1998; revised March 19, 1998.Briefly, primary MEF cells derived from embryos were transfected
with the indicated DNA for 2.5±3 hr. The lipofectamine/DNA mix was
Referencesthen replaced with fresh medium. For analysis of a retinoic acid
response, all trans-retinoic acid was added to the medium one day
Akimaru, H., Hou, D., and Ishii, S. (1997). Drosophila CBP is requiredafter transfection. Transfected cells were harvested 24±36 hr later
for dorsal-dependent twist gene expression. Nat. Genet. 17,and assayed for luciferase activity. b-galactosidase activity was
211±214.measured by a chemiluminescent assay (Tropix) and used as the
Arany, Z., Sellers, W.R., Livingston, D.M., and Eckner, R. (1994). E1A-transfection control. Gal-RAR and the reporter system have been
associated p300 and CREB-associated CBP belong to a conserveddescribed (Forman et al., 1995). CRE-Luc (somatostatin-CRE) is a
family of coactivators. Cell 77, 799±800.gift of Dr. Marc Montminy.
Avantaggiati, M.L., Ogryzko, V., Gardner, K., Giordano, A., Levine,
Genotyping the Mice A.S., and Kelly, K. (1997). Recruitment of p300/CBP in p53-depen-
Tail or yolk sac DNA was prepared by a standard method. The dent signal pathways. Cell 89, 1175±1184.
genotype of the animals was determined either by Southern analysis Bannister, A.J., and Kouzarides, T. (1996). The CBP co-activator is
with a specific probe (described in Figure 2) or by polymerase chain a histone acetyltransferase. Nature 384, 641±643.
reaction (PCR) using specific primers to amplify the neo gene and
Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C., Morin,a specific exon that is deleted in the targeted allele (sequences of
G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E.
the primers available upon request). (1998). Extension of life-span by introduction of telomerase into
normal human cells. Science 279, 349±352.
Western Analysis
Borrow, J., Stanton, V.J., Andresen, J.M., Becher, R., Behm, F.G.,Whole cell extractswere prepared from embryo fibroblasts, fraction-
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et al. (1996). The translocation t(8;16)(p11;p13) of acute myeloidand CBP were detected by staining with p300-specific (RW128) or
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